Navigation Links
Hovione and Solvias Announce a Collaboration to Provide for Improved Drug Solubility

LISBON, Portugal, November 28, 2012 /PRNewswire/ --

Hovione and Solvias today announced the establishment of a collaboration focused on the development and GMP supply of pharmaceutical co-crystals. This strengthens Hovione's expertise and experience in overcoming drug delivery challenges and also the supply of GMP materials from phase I to commercial scale, with Solvias' excellence in solid state chemistry.

Hovione offers a series of innovative particle engineering technologies focused on amorphous solid dispersions, crystal design and reduction and control of particle size. The collaboration provides Hovione access to Solvias' co-crystallization expertise and capabilities, thus reinforcing and complementing the crystal design solutions to overcome poor bioavailability and other drug delivery challenges. Solvias continues its strategy of partnering to enhance access to its solid-state solutions.

"We are delighted to announce this collaboration with Solvias increasing the breadth of drug delivery solutions through our Particle Design offering. Solvias has a tremendous reputation for science, quality and expertise in crystal design for improved drug performance. This agreement reinforces our strategy of combining strengths with innovative companies to allow our customers a seamless and integrated approach to their drug delivery challenges." said Dr. Colin Minchom, Hovione's Vice President of Particle Design.

Dr. Martina Diekmann, Solvias' Global Head of Business Development Analytics commented "Solvias is delighted to work with Hovione.  In establishing this agreement with Hovione, we are able to generate added value for our customers and to help them solving their drug delivery requirements."

About Hovione. Hovione is a global company with over 50 years' experience in Active Pharmaceutical Ingredient and Drug Product Intermediate development and compliant manufacture. With four FDA inspected sites in the U.S., China, Ireland, and Portugal, the company focuses on the most demanding customers in the most regulated markets. Hovione offers integrated API, particle design, formulation development and GMP manufacturing. In the inhalation area, Hovione is the only independent company offering such a broad range of services.

About Solvias. Solvias is a privately held company located in Basel, Switzerland, with recognized high standards as a service provider to the pharmaceutical industry with full cGMP compliance (FDA, Swissmedic). With over 250 highly qualified employees, Solvias supports the research and development of new drug substances and drug products for pharmaceutical and life science companies worldwide.Solvias'profound know-how for analytical and chemical development, its experience and proven track record include:  Analytical Services for small molecules and biopharmaceuticals,;
Solid-State Services: Polymorphism, Salts, and Crystallization; Chemical Development and API Manufacturing up to phase II; Catalysis; Process Analytical Technology.

For more information about Hovione, please visit or contact Marketing & Communication,  Isabel Pina, +351-21-982-9362, e-mail:

For media requests, please contact: Tim Senn, Marketing Communication Manager at or +41-61-845-61-41

SOURCE Hovione
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Robbins Umeda LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Abiomed, Inc.
2. Echo Therapeutics Announces Proposed Public Offering
3. Landauer, Inc. Sets Date And Time For Announcement Of Fiscal Fourth Quarter And Full Year 2012 Results
4. Alere Inc. Announces Offering of $450 Million of Senior Notes
5. Perrigo Announces FDA Final Approval Of Betamethasone Valerate Foam 0.12%
6. SHAREHOLDER ALERT: Morgan & Morgan announces an investigation of Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) and whether senior management and the board of directors violated fiduciary duties owed to Vertex shareholders.
7. Regeneron Announces Presentation at the Deutsche Bank 2012 dbAccess BioFEST
8. Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2012 Fourth Quarter Results And Provides Clinical Study Update
9. Golden Meditech Announces 2012 / 2013 Interim Results
10. TriReme Announces a New Round of Financing Totalling US$18 Million
11. Baby Quasar announces the launch of its next-gen skin care tool, Clear Rayz, for the treatment of acne
Post Your Comments:
(Date:6/23/2016)... Bracket , a leading clinical trial technology ... outcomes platform, Bracket eCOA (SM) 6.0, at the 52 ... 30, 2016 in Philadelphia , Pennsylvania.  A ... product of its kind to fully integrate with RTSM, will ... 6.0 is a flexible platform for electronic clinical outcomes assessments ...
(Date:6/23/2016)... 23, 2016 Revolutionary technology includes ... Oticon , industry leaders in advanced audiology and hearing ... Oticon Opn ™, the world,s first internet connected hearing ... IoT devices.      (Photo: ... number of ,world firsts,: , TwinLink™ - ...
(Date:6/23/2016)... FRANKLIN, Tenn. , June 23, 2016 ... for automating, integrating and transforming the patient ... launch of several innovative new products and ... depth of its revenue cycle offerings. These ... establish more efficient workflows, remain compliant in ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, ... editors can give their videos a whole new perspective by using the title ... Pixel Film Studios. , ProSlice Levels contains over 30 Different presets to choose ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... City, Oklahoma (PRWEB) , ... June 25, 2016 ... ... helping both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic ... the Oklahoma City area —Johnson is one of the first doctors to perform ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
Breaking Medicine News(10 mins):